4//SEC Filing
Jazz Pharmaceuticals plc 4
Accession 0001232524-14-000071
$JAZZCIK 0001232524operating
Filed
Jul 9, 8:00 PM ET
Accepted
Jul 10, 8:14 PM ET
Size
8.7 KB
Accession
0001232524-14-000071
Insider Transaction Report
Form 4
Keegan Fintan
EVP, Technical Operations
Transactions
- Sale
Ordinary Shares
2014-07-08$155.00/sh−1,991$308,605→ 31,750 total - Exercise/Conversion
Ordinary Shares
2014-07-08$46.83/sh+469$21,963→ 33,741 total - Exercise/Conversion
Nonstatutory Stock Option (right to buy)
2014-07-08−469→ 8,531 totalExercise: $46.83Exp: 2022-08-08→ Ordinary Shares (469 underlying)
Footnotes (2)
- [F1]The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F2]This option vests over four years from the grant date of August 9, 2012, with 1/4th vested on August 9, 2013 and the remainder vesting in 36 equal monthly installments thereafter.
Documents
Issuer
Jazz Pharmaceuticals plc
CIK 0001232524
Entity typeoperating
IncorporatedIreland
Related Parties
1- filerCIK 0001232524
Filing Metadata
- Form type
- 4
- Filed
- Jul 9, 8:00 PM ET
- Accepted
- Jul 10, 8:14 PM ET
- Size
- 8.7 KB